Management of postoperative chylous ascites after surgery for ovarian cancer: a single-institution experience.
Aged
Chylous Ascites
/ etiology
Conservative Treatment
Female
Hormones
/ therapeutic use
Humans
Length of Stay
Lymph Node Excision
/ adverse effects
Middle Aged
Neoplasm Staging
Ovarian Neoplasms
/ pathology
Parenteral Nutrition, Total
Postoperative Complications
/ etiology
Retrospective Studies
Risk Factors
Somatostatin
/ therapeutic use
Chylous ascites
Ovarian cancer
Personalized medicine
Total parenteral nutrition
Journal
Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
01
02
2019
accepted:
16
04
2019
pubmed:
22
4
2019
medline:
6
5
2020
entrez:
22
4
2019
Statut:
ppublish
Résumé
Postoperative chylous ascites is a rare complication from operative trauma to the cisterna chyli or lymphatic vessels in the retroperitoneum. In the present study, we aimed to identify the incidence of postoperative chylous ascites in patients treated for ovarian cancer and to describe its management. We retrospectively reviewed all patients submitted to surgery for ovarian cancer at our Institution from October 2016 to November 2018. We analyzed the clinicopathological features, including the primary tumor histology, stage, grade, surgical procedure, median number of harvested pelvic and para-aortic lymph nodes. We described our experience in the diagnosis and management of chylous ascites. Five hundred and forty-six patients were submitted to surgery for ovarian cancer and 298 patients received pelvic and/or para-aortic lymphadenectomy. Chylous ascites occurred in 8 patients with an incidence of 1.4% in the overall population and a 2.68% among patients receiving lymphadenectomy. All patients received total parenteral nutrition (TPN) with Olimel N4E 2000 mL (Baxter
Identifiants
pubmed: 31006086
doi: 10.1007/s13304-019-00656-x
pii: 10.1007/s13304-019-00656-x
doi:
Substances chimiques
Hormones
0
Somatostatin
51110-01-1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
729-734Références
Arch Gynecol Obstet. 2016 Nov;294(6):1291-1298
pubmed: 27535757
Gynecol Oncol. 2012 Oct;127(1):191-7
pubmed: 22728517
Tumour Biol. 2012 Dec;33(6):2117-23
pubmed: 22875782
J Minim Invasive Gynecol. 2018 May - Jun;25(4):644-650
pubmed: 29081384
Prz Menopauzalny. 2018 Mar;17(1):32-38
pubmed: 29725283
Eur J Contracept Reprod Health Care. 2018 Feb;23(1):24-31
pubmed: 29436865
Updates Surg. 2017 Dec;69(4):441-449
pubmed: 28918603
Ann Surg Oncol. 2016 May;23(5):1660-5
pubmed: 26714958
Arch Gynecol Obstet. 2019 Feb;299(2):299-315
pubmed: 30542793
Updates Surg. 2016 Jun;68(2):149-54
pubmed: 26826083
J Minim Invasive Gynecol. 2017 May - Jun;24(4):529-530
pubmed: 27989810
Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:125-129
pubmed: 28753500
Spine (Phila Pa 1976). 1994 Mar 15;19(6):716-8
pubmed: 8009338
J Robot Surg. 2018 Jun;12(2):229-234
pubmed: 28624984
J Urol. 2002 Feb;167(2 Pt 1):449-57
pubmed: 11792897
Gynecol Oncol. 2015 Dec;139(3):433-8
pubmed: 26428942
Ann Surg Oncol. 2015 Jul;22(7):2387-94
pubmed: 25582738
Eur J Gynaecol Oncol. 2016;37(5):671-673
pubmed: 29787008
J Minim Invasive Gynecol. 2014 Jan-Feb;21(1):90-6
pubmed: 23900043
Ann Surg Oncol. 2015 Dec;22(13):4217-23
pubmed: 25808099
J Gynecol Oncol. 2019 May;30(3):e35
pubmed: 30887757
Minerva Ginecol. 2019 Feb;71(1):36-43
pubmed: 30318876
J Sex Med. 2011 Oct;8(10):2841-50
pubmed: 21810188
Int J Gynecol Cancer. 2012 Feb;22(2):186-90
pubmed: 22146765
J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):816-822
pubmed: 29269126
Eur J Surg Oncol. 2016 Mar;42(3):383-90
pubmed: 26725211
Med Oncol. 2017 Aug 20;34(9):164
pubmed: 28825178
J Mal Vasc. 1992;17(2):151-6
pubmed: 1613407
Int J Gynecol Cancer. 2017 May;27(4):696-702
pubmed: 28406844
Ann Ital Chir. 2016;87:461-465
pubmed: 27480601
J Am Coll Surg. 2011 May;212(5):899-905.e1-4
pubmed: 21398159
Updates Surg. 2017 Mar;69(1):75-82
pubmed: 28108938
J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):428-32
pubmed: 25461683
J Urol. 1993 Nov;150(5 Pt 1):1422-4
pubmed: 8411415
Eur J Obstet Gynecol Reprod Biol. 2016 Aug;203:132-5
pubmed: 27289066
J Robot Surg. 2018 Sep;12(3):575-577
pubmed: 29363006
Obstet Gynecol. 2011 Nov;118(5):1111-25
pubmed: 22015880
J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):378-83
pubmed: 26602025
J Urol. 1995 Mar;153(3 Pt 2):976-80
pubmed: 7853586
Ann Ital Chir. 2016;87:608-611
pubmed: 27909270
Int J Hyperthermia. 2018;35(1):370-374
pubmed: 30300042
Arch Gynecol Obstet. 2016 Sep;294(3):615-22
pubmed: 27040423
Expert Rev Anticancer Ther. 2017 Sep;17(9):827-839
pubmed: 28756722
Updates Surg. 2019 Sep;71(3):555-560
pubmed: 30094567
Updates Surg. 2019 Jun;71(2):389-394
pubmed: 30406932
Ann Surg Oncol. 2008 May;15(5):1523-9
pubmed: 18322758
Gynecol Oncol. 2015 Aug;138(2):252-8
pubmed: 26003142
Gynecol Oncol. 2016 Dec;143(3):584-588
pubmed: 27751589
Gynecol Oncol. 2012 Apr;125(1):48-53
pubmed: 22101154
Arch Gynecol Obstet. 2013 May;287(5):1005-8
pubmed: 23224652